Renal Cell Carcinoma Biomarkers
OwnerK.W. Michael SIU, Leroi V. Desouza +2inventors
InventorsK.W. Michael SIU, Leroi V. Desouza, George M. Yousef, Alexander D. Romaschin
Life of this patent
Estimating the term…
Loading patent…
OwnerK.W. Michael SIU, Leroi V. Desouza +2inventors
InventorsK.W. Michael SIU, Leroi V. Desouza, George M. Yousef, Alexander D. Romaschin
Estimating the term…
The invention provides markers for renal cancer, polynucleotides encoding same, and precursors thereof. The invention also provides methods for detecting, diagnosing, screening for, monitoring, assessing, and treating renal cancers and related disease conditions in a subject. The invention further provides a method of selecting for or assessing efficacy of agents against renal cancer, and a method for assessing renal cancer cell carcinogenic potential of a compound. The invention further provides localization and imaging methods for renal cancers. Also provided are diagnostic compositions and kits for carrying out methods of the invention. In addition, the invention provides therapeutic applications for renal cancers which employ protein renal cancer markers and polynucleotides encoding same, miRNA renal cancer markers and precursors thereof, and binding agents for the markers.
A method of screening, diagnosing or monitoring the progression of renal cancer in a subject, the method comprising:
A method for determining in a subject whether renal cancer has metastasized or is likely to metastasize in the future, comprising comparing:
A diagnostic composition comprising:
A method for assessing the potential efficacy of a test agent for inhibiting renal cancer in a subject, comprising comparing:
An in vivo method for imaging a renal disease, comprising:
A kit for determining the presence of renal cancer in a subject, comprising at least one binding agent that binds to a renal cancer marker comprising:
Dependencies are inferred from the claim text.